Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 509 participants.
Also called NCT01294163
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 509 participants
- Registry
-
NCT01294163
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- France, Germany, Italy, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT01294163. Randomized; single masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2015-12-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery
- Condition
- Coronary Artery Disease
- Condition
- General Anesthetic Drug Allergy
- Condition
- Coronary Artery Bypass Graft Surgery
- Intervention (Drug)
- Xenon
- Intervention (Drug)
- Sevoflurane
- Intervention (Drug)
- Propofol
- Lead sponsor
- Air Liquide Santé International
- Collaborator
- Orion Corporation, Orion Pharma
Record details
- Record id
cardio:ct-nct01294163- Content hash
6b0ef4dcf96f69b4c71db291a36c01bcfdbab29f32bad91cb59135204ea8ebea